TCT-45 Cholinesterase Inhibitors Reduce Mortality in Patients With Myocardial Infarction and Alzheimer´s disease.

MLA

Haugaa, Kristina, et al. “TCT-45 Cholinesterase Inhibitors Reduce Mortality in Patients With Myocardial Infarction and Alzheimer´s Disease.” Journal of the American College of Cardiology (JACC), vol. 80, no. 12, Sept. 2022, p. B19. EBSCOhost, https://doi.org/10.1016/j.jacc.2022.08.723.

APA

Haugaa, K., Zetterberg, H., Jurga, J., Religa, D., Eriksdotter, M., Shahim, B., & Xu, H. (2022). TCT-45 Cholinesterase Inhibitors Reduce Mortality in Patients With Myocardial Infarction and Alzheimer´s disease. Journal of the American College of Cardiology (JACC), 80(12), B19. https://doi.org/10.1016/j.jacc.2022.08.723

Chicago

Haugaa, Kristina, Henrik Zetterberg, Juliane Jurga, Dorota Religa, Maria Eriksdotter, Bahira Shahim, and Hong Xu. 2022. “TCT-45 Cholinesterase Inhibitors Reduce Mortality in Patients With Myocardial Infarction and Alzheimer´s Disease.” Journal of the American College of Cardiology (JACC) 80 (12): B19. doi:10.1016/j.jacc.2022.08.723.